GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MedCap AB (OSTO:MCAP) » Definitions » LT-Debt-to-Total-Asset

MedCap AB (OSTO:MCAP) LT-Debt-to-Total-Asset : 0.15 (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is MedCap AB LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. MedCap AB's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.15.

MedCap AB's long-term debt to total assets ratio increased from Dec. 2023 (0.12) to Dec. 2024 (0.15). It may suggest that MedCap AB is progressively becoming more dependent on debt to grow their business.


MedCap AB LT-Debt-to-Total-Asset Historical Data

The historical data trend for MedCap AB's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedCap AB LT-Debt-to-Total-Asset Chart

MedCap AB Annual Data
Trend Apr15 Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.14 0.16 0.12 0.15

MedCap AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.13 0.16 0.16 0.15

MedCap AB LT-Debt-to-Total-Asset Calculation

MedCap AB's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )/Total Assets (A: Dec. 2024 )
=297.4/1991.4
=0.15

MedCap AB's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=297.4/1991.4
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedCap AB  (OSTO:MCAP) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


MedCap AB LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of MedCap AB's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


MedCap AB Business Description

Traded in Other Exchanges
Address
Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.

MedCap AB Headlines

From GuruFocus

MCAP Inc. Expands ETF Division and Announces Senior Hire

By PRNewswire PRNewswire 10-19-2022

MCAP Inc. Reports First Quarter 2022 EPS of $0.15 Per Share

By PRNewswire PRNewswire 06-08-2022

MCAP Inc. Announces Acquisition of QwickBonds

By PRNewswire PRNewswire 02-02-2023

MCAP Inc. Expands ETF Division and Announces Senior Hire

By PRNewswire PRNewswire 05-04-2022

Mango Capital, Inc. Announces Name Change and Reverse Split

By ACCESSWIRE ACCESSWIRE 11-03-2021

MCAP Inc. Reports First Quarter 2023 EPS of $0.10 Per Share

By PRNewswire PRNewswire 05-09-2023